Company Filing History:
Years Active: 1998
Title: The Innovations of Peter Baxter Wingrove
Introduction
Peter Baxter Wingrove is a notable inventor based in Sawbridgeworth, GB. He has made significant contributions to the field of biotechnology, particularly in the development of cell lines for medical research. His work focuses on the expression of human GABA-A receptors, which are crucial for understanding various neurological conditions.
Latest Patents
Peter Baxter Wingrove holds 1 patent for his invention titled "Stably human transfected rodent fibroblast cell line expressing human." This patent relates to a stably co-transfected eukaryotic cell line capable of expressing a GABA-A receptor, specifically a human GABA-A receptor. The invention includes the cloning of novel cDNA sequences encoding the alpha-2, alpha-3, alpha-5, alpha-6, and beta-2 subunits of the human GABA-A receptor. The cell line developed through this invention is intended for use in designing and developing GABA-A receptor subtype-selective medicaments.
Career Highlights
Peter has had a distinguished career, working with Merck Sharpe & Dohme Corp., a leading global healthcare company. His expertise in biotechnology and cell line development has positioned him as a valuable asset in the field of pharmaceutical research.
Collaborations
Throughout his career, Peter has collaborated with several talented individuals, including Karen Louise Hadingham and Beatrice Le Bourdelles. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Peter Baxter Wingrove's contributions to biotechnology and his innovative patent on GABA-A receptor expression highlight his importance in the field. His work continues to pave the way for advancements in medical research and therapeutic development.